Actively Recruiting

Age: 18Years - 80Years
MALE
NCT06341699

Study of the Steroid Hormone Milieu in Obese Patients

Led by Istituto Auxologico Italiano · Updated on 2025-05-13

180

Participants Needed

1

Research Sites

163 weeks

Total Duration

On this page

Sponsors

I

Istituto Auxologico Italiano

Lead Sponsor

M

Ministry of Health, Italy

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of this observational study is to evaluate the actual secretion of cortisol and testosterone in obese male subjects, together with the receptor sensitivity to these hormones in order to understand whether the hormonal milieu deriving from these parameters is associated with alterations in bone metabolism, lipoprotein concentration and function, and/or the severity and complications of obesity. It will be also investigated if this hormonal milieu is a predictive factor for cardiovascular disease in obese patients. Eligible subjects are male patients (age 18-80 years) with severe obesity and no other known causes of hypercortisolism or hypogonadism. Questionnaires for the evaluation of mood and symptoms will be collected upon enrollment, patient's anamnestic and clinical data relating to disease complications, BMI, previous blood tests, cortisol suppression with dexamethasone 1 mg will be collected, and blood sample will be sent to and analyzed at a centralized laboratory for the study of Steroid hormones, bone metabolism, lipoprotein function, genetics and receptor analysis.

CONDITIONS

Official Title

Study of the Steroid Hormone Milieu in Obese Patients

Who Can Participate

Age: 18Years - 80Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male patients aged 18 to 80 years
  • Diagnosis of morbid obesity
Not Eligible

You will not qualify if you...

  • Severe systemic diseases, fever, or chronic inflammatory conditions with PCR greater than 10 mg/dL
  • Current use of corticosteroids
  • Poor understanding of spoken and written Italian
  • Known primary diseases of the testicle
  • Known hypothalamic-pituitary or adrenal gland diseases at enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Istituto Auxlogico Italiano, Hospital San Giuseppe, Piancavallo

Oggebbio, Verbania, Italy, 28824

Actively Recruiting

Loading map...

Research Team

B

Biagio Cangiano, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here